Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P384: The usefulness of salazosulfapyridine for 
patients with ulcerative colitis refractory to mesalazineECCO '16 Amsterdam
Year: 2016
Authors:

T. Yoshino*, S. Yazumi

Kitano Hospital, Division of Gastroenterology and Hepatology, Digestive Disease Centre, Osaka, Japan

P385: Predictors of tissue healing in ulcerative colitis patients treated with anti-TNFECCO '16 Amsterdam
Year: 2016
Authors:

N. Viazis*1, M. Giakoumis1, G. Bamias2, D. Goukos2, T. Koukouratos1, J. Anastasiou1, K. Katopodi1, S. Ladas2, D. Karamanolis1

1Evangelismos Hospital, Gastroenterology Department, Athens, Greece, 2Kapodistrian University of Athens, Laikon Hospital, Academic Department of Gastroenterology, Athens, Greece

P386: Anti-TNF alpha as induction and maintenance therapy in ulcerative colitis patients in the BioColitis Registry in GermanyECCO '16 Amsterdam
Year: 2016
Authors:

B. Bokemeyer*1, T. Krummenerl2, C. Maaser3, J. Büning4, R. Atreya5, A. Lügering6, U. Helwig7, P. Jessen8, P. Hartmann9, S. Schreiber10

1Gastroenterology Practice Minden, University Hospital Schleswig-Holstein, Department of General Internal Medicine I, Kiel, Germany, Minden, Germany, 2Gastroenterology Practice, Gastroenterology, Münster, Germany, 3University Teaching Hospital Lüneburg, IBD Outpatient Clinic and Department of Geriatric Medicine, Lüneburg, Germany, 4University Hospital Schleswig-Holstein, Campus Lübeck, Medical Department I, Gastroenterology, Lübeck, Germany, 5University of Erlangen-Nuremberg, Department of Medicine 1, Erlangen, Germany, 6Gastroenterology Practice Münster, Münster, Germany, 7Gastroenterology Practice Oldenburg, Oldenburg, Germany, 8Gastroenterology Practice, Gastroenterology, Altenholz, Germany, 9Gastroenterology Practice, Minden, Germany, 10Christian-Albrechts-Universität, University Hospital Schleswig-Holstein, Department of General Internal Medicine I, Kiel, Germany

P387: Does standard therapy in paediatric Crohn’s disease really prevent our patients from the need of early initiation of anti-TNF treatment?ECCO '16 Amsterdam
Year: 2016
Authors:

P. Domínguez Sánchez*, G. Pujol Muncunill, S. Pinillos Pison, V. Vila Miravet, J. Martín de Carpi

Unit for the Comprehensive Care of Paediatric Inflammatory Bowel Disease. Department of Paediatric Gastroenterology, Hepatology and Nutrition. Hospital Sant Joan de Déu, Barcelona, Spain

P388: Clinical care pathways are needed to decrease variability in the management of the hospitalised ulcerative colitis patientECCO '16 Amsterdam
Year: 2016
Authors:

S. Shah*, S. Naymagon, B. Cohen, B. Sands, M. Dubinsky

Mount Sinai Hospital, Gastroenterology, New York, New York, United States

P389: The value of oxidative stress parameters to predict histological severity in ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

B. Canbakan*1, K. Atay1, E. Koroglu1, M. Tuncer1, H. Senturk2

1Istanbul University Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey, 2Bezmialem University School of Medicine, Gastroenterology, Istanbul, Turkey

P390: To double dose or not to double dose? That is the question: Single centre experience in the use of infliximab antibodies and levels in a paediatric IBD (pIBD) cohortECCO '16 Amsterdam
Year: 2016
Authors:

B. Huggett*, S. Sider, S. Chadokufa, N. Acton, N. Shah, F. Kiparissi

Great Ormond Street Hospital, London, United Kingdom

P391: Gender differences in adalimumab continuation rates: Results of a Crohn’s disease cohortECCO '16 Amsterdam
Year: 2016
Authors:

M. Lie*, J. Kreijne, J. van der Woude

Erasmus MC, Gastroenterology and Hepatology, Rotterdam, Netherlands

P392: Comparing the accuracy and ease of use of self-administered ‘Malnutrition Universal Screening Tool’ (MUST) to screening by a health care professional using MUST to explore malnutrition rates in an outpatient inflammatory bowel disease clinicECCO '16 Amsterdam
Year: 2016
Authors:

S. Zacharopoulou-Otapasidou*1, K. Keetarut1, S. Bloom2, S. McCartney2

1University College London Hospital, Nutrition and Dietetics Department, London, United Kingdom, 2University College London Hospital, Department of Gastroenterology, London, United Kingdom

P393: Investigation of Crohn’s disease patients receiving anti-TNF α therapy after surgery for intestinal stenosisECCO '16 Amsterdam
Year: 2016
Authors:

T. Kuriyama*, B. Iizuka, H. Kashiwagi, T. Hara, A. Ito, T. Omori, M. Yonezawa, K. Tokushige

Tokyo Women’s Medical University, Gastroenterology, Tokyo, Japan

P394: Psychosexual dysfunction in a cohort of Greek inflammatory bowel disease patients in clinical remission: preliminary resultsECCO '16 Amsterdam
Year: 2016
Authors:

D. Xanthis*, K. Soufleris, E. Gavalas, P. Anyfanti, G. Chatzinakos, N. Grammatikos, A. Tsimperidis, O. Giouleme

Aristotle University of Thessaloniki, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece

P395: Real-life prospective experience with adalimumab in ulcerative colitis in Italy: preliminary results of a pilot studyECCO '16 Amsterdam
Year: 2016
Authors:

M. Daperno*1, A. Armuzzi2, D. Pugliese2, A. Lavagna1, P. Gionchetti3, F. Rizzello3

1AO Ordine Mauriziano, Gastroenterology Unit, Torino, Italy, 2Complesso Integrato Columbus, Internal Medicine, Roma, Italy, 3AO S. Orsola-Malpighi & University, Internal Medicine, Bologna, Italy

P396: Cyclosporin A efficacy in a paediatric ulcerative colitis: a retrospective single-centre studyECCO '16 Amsterdam
Year: 2016
Authors:

M. Osiecki*, M. Dadalski, J. Kierkus

The Children’s Memorial Health Institute, Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, Warsaw, Poland

P397: Efficacy and safety of sequential rescue therapy with infliximab and tacrolimus in patients with corticosteroid-refractory ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

K. Matsuoka*, E. Saito, T. Fujii, K. Takenaka, F. Iwamoto, M. Kimura, M. Nagahori, K. Ohtsuka, M. Watanabe

Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan

P398: The costs of care for patients with ulcerative colitis: effect of adalimumab on health care resources utilisation in clinical practice from INSPIRADAECCO '16 Amsterdam
Year: 2016
Authors:

S. Travis*1, B. Feagan2, L. Peyrin-Biroulet3, R. Panaccione4, S. Danese5, A. Lazar6, A. Robinson7, J. Petersson7, M. Bereswill6, M. Skup7, N. Chen7, S. Wang7, R. Thakkar7, J. Chao7

1Oxford University Hospitals, Oxford, United Kingdom, 2Robarts Research Institute, Ontario, Canada, 3University Hospital of Nancy, Les Nancy, France, 4University of Calgary, Calgary, Canada, 5Istituto Clinico Humanitas, Milan, Italy, 6AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 7AbbVie Inc., North Chicago, United States

P399: Testing patients initiating anti-TNFα agents for mycobacterial infection using interferon-gamma release assays (IGRA): The combined experience of a large dermatology and Inflammatory Bowel Disease serviceECCO '16 Amsterdam
Year: 2016
Authors:

S. Rajagopal*1, K. Greveson2, S. McBride3, A. Waite3, M. Lipman4, C. Murray2

1University College London, Medicine, London, United Kingdom, 2Royal Free Hospital, Centre for Gastroenterology, London, United Kingdom, 3Royal Free Hospital, Centre for Dermatology, London, United Kingdom, 4Royal Free Hospital, Respiratory Medicine, London, United Kingdom

P400: Anti-TNF treatment for extraintestinal manifestations of inflammatory bowel disease in the Swiss IBD Cohort StudyECCO '16 Amsterdam
Year: 2016
Authors:

T. Greuter*1, L. Biedermann1, G. Rogler1, E. Safroneeva2, A. Schoepfer3, S. Vavricka1, 4

1University Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland, 2University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 3University Hospital Lausanne - CHUV, Division of Gastroenterology and Hepatology, Lausanne, Switzerland, 4Triemli Hospital Zurich, Division of Gastroenterology and Hepatology, Zurich, Switzerland

P401: Confocal laser endomicroscopy predicts response in patients with acute inflammatory bowel disease undergoing anti-integrin therapy with vedolizumabECCO '16 Amsterdam
Year: 2016
Authors:

M. Ellrichmann*1, J. Bethge1, G. Aust1, A. Arlt1, B. Brandt1, S. Zeissig1, 2, S. Nikolaus1, K. Aden1, S. Schreiber1

1University Hospital Schleswig-Holstein, Campus Kiel, Medical Department I, Kiel, Germany, 2University Hospital Dresden, Department of Gastroenterology, Dresden, Germany

P402: A novel high-dose mesalazine tablet is as effective as conventional low-dose mesalazine tablets in inducing remission in patients with mildly to moderately active ulcerative colitis (UC): A double-blind, double-dummy, multicentre, randomised trialECCO '16 Amsterdam
Year: 2016
Authors:

A. Dignaß*1, R. Schnabel2, J. Romatowski3, V. Pavlenko4, A. Dorofeyev5, J. Derova6, L. Jonaitis7, T. Nacak8, R. Greinwald8

1Agaplesion Markus Krankenhaus, Dept. of Medicine I, Frankfurt a.M., Germany, 2Pannónia Magánorvosi Centrum Kft, Budapest, Hungary, 3Gastromed sc, Bialystok, Poland, 4Stavropol State Medical University, Stavropol, Russian Federation, 5Regional Bowel Diseases Centre of Donetsk State Medical University, Donetsk, Ukraine, 6Latvian Maritime Medical Centre, Riga, Latvia, 7Lithuanian University of Health Sciences, Dept. of Gastroenterology, Kaunas, Lithuania, 8Dr. Falk Pharma GmbH, Clinical Research, Freiburg, Germany

P403: Combined therapy with anti-TNF and immunomodulator is superior to monotherapy for postoperative prophylaxis in Crohn’s disease after intestinal resection: a retrospective analysis from a tertiary centreECCO '16 Amsterdam
Year: 2016
Authors:

A. O’Connor*1, J. Taylor1, N. Scott2, C. Selinger1, J. Hamlin1, A. Ford1, 3

1Leeds Gastroenterology Institute, Leeds, United Kingdom, 2St James’s University Hospital, Histopathology, Leeds, United Kingdom, 3University of Leeds, Leeds Institute of Biochemical and Clinical Sciences, Leeds, United Kingdom